Press releases

16
Dec 2016
21:30 E.S.T.

Cellectis Announces Conference Call To Discuss Recent Recombinant DNA Advisory Committee (RAC) Meeting

Read more
15
Dec 2016
21:30 E.S.T.

Cellectis Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of UCART123 Phase 1 Study Protocols in AML and BPDCN

Read more
22
Nov 2016
21:30 E.S.T.

Cellectis Reports Financial Results for 3rd Quarter and First Nine Months 2016

Read more
21
Nov 2016
21:30 E.S.T.

Cellectis to Participate in Oppenheimer Life Sciences Summit, NY & in Piper Jaffray 28th Annual Health Care Conference, NY

Read more
15
Nov 2016
21:30 E.S.T.

Cellectis Announces Successful cGMP Manufacturing for Second Product Candidate: UCART123

Read more
31
Oct 2016
20:30 E.S.T.

Cellectis Hosts World’s First Gene Edited Dinner in NYC

Read more
4
Oct 2016
20:30 E.S.T.

Cellectis Announces the Issuance of U.S. Patent 9,458,439 Following U.S. Patent 8,921,332 Issued in December 2014

Read more
28
Sep 2016
20:30 E.S.T.

Cellectis Wins 2016 Most Innovative European Biotech SME Award for Healthcare

Read more
9
Sep 2016
20:30 E.S.T.

Cellectis Reports 2nd Quarter and First Half Year 2016 Financial Results

Read more
27
Jun 2016
20:30 E.S.T.

Cellectis Named 2016 Technology Pioneer by the World Economic Forum

Read more

Press contacts

For more information on any story, or for press enquiries, get in touch with our communication team

CONTACT US